The DOI matches its Crossref record; 173 of the 173 references it cites were found in a registry or an index.
Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology
Abstract
Multiple myeloma is a malignant neoplasm of plasma cells that accumulate in bone marrow, leading to bone destruction and marrow failure. This manuscript discusses the management of patients with solitary plasmacytoma, smoldering multiple myeloma, and newly diagnosed multiple myeloma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21590 · Cited by 20,444
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
Rajkumar, S. V., Dimopoulos, M. A., Palumbo, A., Blade, J., Merlini, G., Mateos, M.-V., Kumar, S., Hillengass, J., Kastritis, E., Richardson, P., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70442-5 · Cited by 4,978
Self-citationKumar, S., Paiva, B., Anderson, K. C., Durie, B., Landgren, O., Moreau, P., Munshi, N., Lonial, S., Bladé, J., Mateos, M.-V., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30206-6 · Cited by 3,061
Self-citationInternational Staging System for Multiple Myeloma
Greipp, P. R., Miguel, J. S., Durie, B. G. M., Crowley, J. J., Barlogie, B., Bladé, J., Boccadoro, M., Child, J. A., Avet-Loiseau, H., Kyle, R. A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.242 · Cited by 2,974
International uniform response criteria for multiple myeloma
Durie, B. G. M., Harousseau, J.-L., Miguel, J. S., Bladé, J., Barlogie, B., Anderson, K., Gertz, M., Dimopoulos, M., Westin, J., Sonneveld, P., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404284 · Cited by 2,632
Attal, M., Harousseau, J.-L., Stoppa, A.-M., Sotto, J.-J., Fuzibet, J.-G., Rossi, J.-F., Casassus, P., Maisonneuve, H., Facon, T., Ifrah, N., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607113350204 · Cited by 2,548
Bortezomib or High-Dose Dexamethasone for Relapsed Multiple Myeloma
Richardson, P. G., Sonneveld, P., Schuster, M. W., Irwin, D., Stadtmauer, E. A., Facon, T., Harousseau, J.-L., Ben-Yehuda, D., Lonial, S., Goldschmidt, H., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043445 · Cited by 2,491
Review of 1027 Patients With Newly Diagnosed Multiple Myeloma
Kyle, R. A., Gertz, M. A., Witzig, T. E., Lust, J. A., Lacy, M. Q., Dispenzieri, A., Fonseca, R., Rajkumar, S. V., Offord, J. R., Larson, D. R., et al. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.1.21 · Cited by 2,447
The International Myeloma Working Group (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04355.x · Cited by 2,321
Palumbo, A., Avet-Loiseau, H., Oliva, S., Lokhorst, H. M., Goldschmidt, H., Rosinol, L., Richardson, P., Caltagirone, S., Lahuerta, J. J., Facon, T., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.2267 · Cited by 2,210
Self-citationTtal, M. I. A., Ean, J., Dünne, A. A., Toppa, A. S., Ossi, R. G., Hilippe, P., Asassus, C., Acon, T. H. F., Orbert, N., Ayen, C. A. P., et al. (2013) · Cited by 2,161
High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma
Child, J. A., Morgan, G. J., Davies, F. E., Owen, R. G., Bell, S. E., Hawkins, K., Brown, J., Drayson, M. T., & Selby, P. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022340 · Cited by 1,768
Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma
Attal, M., Lauwers-Cances, V., Hulin, C., Leleu, X., Caillot, D., Escoffre, M., Arnulf, B., Macro, M., Belhadj, K., Garderet, L., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611750 · Cited by 1,257
Lenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma
Mateos, M.-V., Hernández, M.-T., Giraldo, P., de la Rubia, J., de Arriba, F., Corral, L. L., Rosiñol, L., Paiva, B., Palomera, L., Bargay, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1300439 · Cited by 1,171
Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma
Attal, M., Lauwers-Cances, V., Marit, G., Caillot, D., Moreau, P., Facon, T., Stoppa, A. M., Hulin, C., Benboubker, L., Garderet, L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1114138 · Cited by 1,155
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
McCarthy, P. L., Owzar, K., Hofmeister, C. C., Hurd, D. D., Hassoun, H., Richardson, P. G., Giralt, S., Stadtmauer, E. A., Weisdorf, D. J., Vij, R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1114083 · Cited by 1,147
Self-citationEfficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma
Berenson, J. R., Lichtenstein, A., Porter, L., Dimopoulos, M. A., Bordoni, R., George, S., Lipton, A., Keller, A., Ballester, O., Kovacs, M. J., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602223340802 · Cited by 1,081
Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma
Facon, T., Kumar, S., Plesner, T., Orlowski, R. Z., Moreau, P., Bahlis, N., Basu, S., Nahi, H., Hulin, C., Quach, H., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1817249 · Cited by 1,045
Self-citationDaratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma
Mateos, M.-V., Dimopoulos, M. A., Cavo, M., Suzuki, K., Jakubowiak, A., Knop, S., Doyen, C., Lucio, P., Nagy, Z., Kaplan, P., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1714678 · Cited by 988
Single versus Double Autologous Stem-Cell Transplantation for Multiple Myeloma
Attal, M., Harousseau, J.-L., Facon, T., Guilhot, F., Doyen, C., Fuzibet, J.-G., Monconduit, M., Hulin, C., Caillot, D., Bouabdallah, R., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa032290 · Cited by 984
Moreau, P., Attal, M., Hulin, C., Arnulf, B., Belhadj, K., Benboubker, L., Béné, M. C., Broijl, A., Caillon, H., Caillot, D., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31240-1 · Cited by 967
Rajkumar, S. V., Jacobus, S., Callander, N. S., Fonseca, R., Vesole, D. H., Williams, M. E., Abonour, R., Siegel, D. S., Katz, M., & Greipp, P. R. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70284-0 · Cited by 933
Self-citationClinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma
Kyle, R. A., Remstein, E. D., Therneau, T. M., Dispenzieri, A., Kurtin, P. J., Hodnefield, J. M., Larson, D. R., Plevak, M. F., Jelinek, D. F., Fonseca, R., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070389 · Cited by 921
Moreau, P., Pylypenko, H., Grosicki, S., Karamanesht, I., Leleu, X., Grishunina, M., Rekhtman, G., Masliak, Z., Robak, T., Shubina, A., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70081-x · Cited by 920
Avet-Loiseau, H., Attal, M., Moreau, P., Charbonnel, C., Garban, F., Hulin, C., Leyvraz, S., Michallet, M., Yakoub-Agha, I., Garderet, L., et al. (2007) · Blood · doi:10.1182/blood-2006-08-040410 · Cited by 911
Durie, B. G. M., Hoering, A., Abidi, M. H., Rajkumar, S. V., Epstein, J., Kahanic, S. P., Thakuri, M., Reu, F., Reynolds, C. M., Sexton, R., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31594-x · Cited by 908
Randomized trial of lenalidomide versus observation in smoldering multiple myeloma
Lonial, S., Jacobus, S., Fonseca, R., Weiss, M., Kumar, S., Orlowski, R. Z., Kaufman, J. L., Yacoub, A. M., Buadi, F. K., O’Brien, T., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.01740 · Cited by 908
Self-citationRichardson, P. G., Weller, E., Lonial, S., Jakubowiak, A. J., Jagannath, S., Raje, N. S., Avigan, D. E., Xie, W., Ghobrial, I. M., Schlossman, R. L., et al. (2010) · Blood · doi:10.1182/blood-2010-02-268862 · Cited by 861
Major, P., Lortholary, A., Hon, J., Abdi, E., Mills, G., Menssen, H. D., Yunus, F., Bell, R., Body, J., Quebe-Fehling, E., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.558 · Cited by 858
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma
Palumbo, A., Rajkumar, S. V., Dimopoulos, M. A., Richardson, P. G., San Miguel, J., Barlogie, B., Harousseau, J., Zonder, J. A., Cavo, M., Zangari, M., et al. (2008) · Leukemia · doi:10.1038/sj.leu.2405062 · Cited by 840
Self-citationSonneveld, P., Schmidt-Wolf, I. G. H., van der Holt, B., el Jarari, L., Bertsch, U., Salwender, H., Zweegman, S., Vellenga, E., Broyl, A., Blau, I. W., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.6820 · Cited by 824
Cavo, M., Tacchetti, P., Patriarca, F., Petrucci, M. T., Pantani, L., Galli, M., Di Raimondo, F., Crippa, C., Zamagni, E., Palumbo, A., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61424-9 · Cited by 819
Single versus Double Autologous Stem-Cell Transplantation for Multiple Myeloma
(2004) · New England Journal of Medicine · doi:10.1056/nejm200406173502526 · Cited by 817
Dispenzieri, A., Kyle, R., Merlini, G., Miguel, J. S., Ludwig, H., Hajek, R., Palumbo, A., Jagannath, S., Blade, J., Lonial, S., et al. (2009) · Leukemia · doi:10.1038/leu.2008.307 · Cited by 815
Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma
Benboubker, L., Dimopoulos, M. A., Dispenzieri, A., Catalano, J., Belch, A. R., Cavo, M., Pinto, A., Weisel, K., Ludwig, H., Bahlis, N., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402551 · Cited by 793
Autologous Transplantation and Maintenance Therapy in Multiple Myeloma
Palumbo, A., Cavallo, F., Gay, F., Di Raimondo, F., Ben Yehuda, D., Petrucci, M. T., Pezzatti, S., Caravita, T., Cerrato, C., Ribakovsky, E., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402888 · Cited by 778
Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma
Palumbo, A., Hajek, R., Delforge, M., Kropff, M., Petrucci, M. T., Catalano, J., Gisslinger, H., Wiktor-Jędrzejczak, W., Zodelava, M., Weisel, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112704 · Cited by 741
McCarthy, P. L., Holstein, S. A., Petrucci, M. T., Richardson, P. G., Hulin, C., Tosi, P., Bringhen, S., Musto, P., Anderson, K. C., Caillot, D., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.72.6679 · Cited by 698
Voorhees, P. M., Kaufman, J. L., Laubach, J., Sborov, D. W., Reeves, B., Rodriguez, C., Chari, A., Silbermann, R., Costa, L. J., Anderson, L. D., et al. (2020) · Blood · doi:10.1182/blood.2020005288 · Cited by 693
Self-citationFlow cytometric immunophenotyping for hematologic neoplasms
Craig, F. E., & Foon, K. A. (2008) · Blood · doi:10.1182/blood-2007-11-120535 · Cited by 672
Berenson, J. R., Lichtenstein, A., Porter, L., Dimopoulos, M. A., Bordoni, R., George, S., Lipton, A., Keller, A., Ballester, O., Kovacs, M., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.593 · Cited by 648
Kumar, S. K., Mikhael, J. R., Buadi, F. K., Dingli, D., Dispenzieri, A., Fonseca, R., Gertz, M. A., Greipp, P. R., Hayman, S. R., Kyle, R. A., et al. (2009) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0603 · Cited by 628
Self-citationMorgan, G. J., Davies, F. E., Gregory, W. M., Cocks, K., Bell, S. E., Szubert, A. J., Navarro-Coy, N., Drayson, M. T., Owen, R. G., Feyler, S., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)62051-x · Cited by 575
Moreau, P. (2002) · Blood · doi:10.1182/blood.v99.3.731 · Cited by 564
Graft-versus-myeloma effect: proof of principle
Tricot, G., Vesole, D., Jagannath, S., Hilton, J., Munshi, N., & Barlogie, B. (1996) · Blood · doi:10.1182/blood.v87.3.1196.bloodjournal8731196 · Cited by 543
Harousseau, J.-L., Attal, M., Avet-Loiseau, H., Marit, G., Caillot, D., Mohty, M., Lenain, P., Hulin, C., Facon, T., Casassus, P., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.9158 · Cited by 532
Barlogie, B., Kyle, R. A., Anderson, K. C., Greipp, P. R., Lazarus, H. M., Hurd, D. D., McCoy, J., Moore, D. F., Dakhil, S. R., Lanier, K. S., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.5807 · Cited by 495
Rosiñol, L., Oriol, A., Teruel, A. I., Hernández, D., López-Jiménez, J., de la Rubia, J., Granell, M., Besalduch, J., Palomera, L., González, Y., et al. (2012) · Blood · doi:10.1182/blood-2012-02-408922 · Cited by 486
Hanamura, I., Stewart, J. P., Huang, Y., Zhan, F., Santra, M., Sawyer, J. R., Hollmig, K., Zangarri, M., Pineda-Roman, M., van Rhee, F., et al. (2006) · Blood · doi:10.1182/blood-2006-03-009910 · Cited by 479
Paiva, B., Vidriales, M.-B., Cerveró, J., Mateo, G., Pérez, J. J., Montalbán, M. A., Sureda, A., Montejano, L., Gutiérrez, N. C., de Coca, A. G., et al. (2008) · Blood · doi:10.1182/blood-2008-05-159624 · Cited by 477
Raje, N., Terpos, E., Willenbacher, W., Shimizu, K., García-Sanz, R., Durie, B., Legieć, W., Krejčí, M., Laribi, K., Zhu, L., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30072-x · Cited by 449
Kumar, S., Flinn, I., Richardson, P. G., Hari, P., Callander, N., Noga, S. J., Stewart, A. K., Turturro, F., Rifkin, R., Wolf, J., et al. (2012) · Blood · doi:10.1182/blood-2011-11-395749 · Cited by 446
Self-citationErythropoietin Treatment of Anemia Associated with Multiple Myeloma
Ludwig, H., Fritz, E., Kotzmann, H., Höcker, P., Gisslinger, H., & Barnas, U. (1990) · New England Journal of Medicine · doi:10.1056/nejm199006143222402 · Cited by 443
Carrasco, D. R., Tonon, G., Huang, Y., Zhang, Y., Sinha, R., Feng, B., Stewart, J. P., Zhan, F., Khatry, D., Protopopova, M., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.019 · Cited by 425
Jakubowiak, A. J., Dytfeld, D., Griffith, K. A., Lebovic, D., Vesole, D. H., Jagannath, S., Al-Zoubi, A., Anderson, T., Nordgren, B., Detweiler-Short, K., et al. (2012) · Blood · doi:10.1182/blood-2012-04-422683 · Cited by 423
Self-citationRawstron, A. C., Child, J. A., de Tute, R. M., Davies, F. E., Gregory, W. M., Bell, S. E., Szubert, A. J., Navarro-Coy, N., Drayson, M. T., Feyler, S., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.2119 · Cited by 415
Fermand, J.-P., Katsahian, S., Divine, M., Leblond, V., Dreyfus, F., Macro, M., Arnulf, B., Royer, B., Mariette, X., Pertuiset, E., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.0551 · Cited by 399
Palumbo, A., Rajkumar, S. V., San Miguel, J. F., Larocca, A., Niesvizky, R., Morgan, G., Landgren, O., Hajek, R., Einsele, H., Anderson, K. C., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.48.7934 · Cited by 392
Mateos, M.-V., Hernández, J.-M., Hernández, M.-T., Gutiérrez, N.-C., Palomera, L., Fuertes, M., Díaz-Mediavilla, J., Lahuerta, J.-J., de la Rubia, J., Terol, M.-J., et al. (2006) · Blood · doi:10.1182/blood-2006-04-019778 · Cited by 389
Hillengass, J., Fechtner, K., Weber, M.-A., Bäuerle, T., Ayyaz, S., Heiss, C., Hielscher, T., Moehler, T. M., Egerer, G., Neben, K., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.5356 · Cited by 381
Self-citationReeder, C. B., Reece, D. E., Kukreti, V, Chen, C., Trudel, S., Hentz, J., Noble, B., Pirooz, N. A., Spong, J. E., Piza, J. G., et al. (2009) · Leukemia · doi:10.1038/leu.2009.26 · Cited by 372
Cavo, M., Tosi, P., Zamagni, E., Cellini, C., Tacchetti, P., Patriarca, F., Di Raimondo, F., Volpe, E., Ronconi, S., Cangini, D., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.2509 · Cited by 370
Gertz, M. A. (2005) · Blood · doi:10.1182/blood-2005-04-1411 · Cited by 360
Himelstein, A. L., Foster, J. C., Khatcheressian, J. L., Roberts, J. D., Seisler, D. K., Novotny, P. J., Qin, R., Go, R. S., Grubbs, S. S., O’Connor, T., et al. (2017) · JAMA · doi:10.1001/jama.2016.19425 · Cited by 356
Siegel, D., Martin, T., Nooka, A., Harvey, R. D., Vij, R., Niesvizky, R., Badros, A. Z., Jagannath, S., McCulloch, L., Rajangam, K., et al. (2013) · Haematologica · doi:10.3324/haematol.2013.089334 · Cited by 347
Self-citationBarlogie, B., Anaissie, E., Van Rhee, F., Haessler, J., Hollmig, K., Pineda‐Roman, M., Cottler‐Fox, M., Mohiuddin, A., Alsayed, Y., Tricot, G., et al. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06639.x · Cited by 331
Drach, J., Ackermann, J., Fritz, E., Krömer, E., Schuster, R., Gisslinger, H., DeSantis, M., Zojer, N., Fiegl, M., Roka, S., et al. (1998) · Blood · doi:10.1182/blood.v92.3.802 · Cited by 325
Ross, F. M., Avet-Loiseau, H., Ameye, G., Gutierrez, N. C., Liebisch, P., O'Connor, S., Dalva, K., Fabris, S., Testi, A. M., Jarosova, M., et al. (2012) · Haematologica · doi:10.3324/haematol.2011.056176 · Cited by 322
Greipp, P., Lust, J., O'Fallon, W., Katzmann, J., Witzig, T., & Kyle, R. (1993) · Blood · doi:10.1182/blood.v81.12.3382.3382 · Cited by 312
Cavo, M., Pantani, L., Petrucci, M. T., Patriarca, F., Zamagni, E., Donnarumma, D., Crippa, C., Boccadoro, M., Perrone, G., Falcone, A., et al. (2012) · Blood · doi:10.1182/blood-2012-02-408898 · Cited by 308
Korde, N., Roschewski, M., Zingone, A., Kwok, M., Manasanch, E. E., Bhutani, M., Tageja, N., Kazandjian, D., Mailankody, S., Wu, P., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.2010 · Cited by 307
Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria
Lakshman, A., Rajkumar, S. V., Buadi, F. K., Binder, M., Gertz, M. A., Lacy, M. Q., Dispenzieri, A., Dingli, D., Fonder, A. L., Hayman, S. R., et al. (2018) · Blood Cancer Journal · doi:10.1038/s41408-018-0077-4 · Cited by 303
Self-citationThe multiple myelomas — current concepts in cytogenetic classification and therapy
Kumar, S. K., & Rajkumar, S. V. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0018-y · Cited by 302
Self-citationZervas, K., Verrou, E., Teleioudis, Z., Vahtsevanos, K., Banti, A., Mihou, D., Krikelis, D., & Terpos, E. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06230.x · Cited by 297
Lokhorst, H. M., Schattenberg, A. V. M. B., Cornelissen, J. J., Thomas, L. L. M., & Verdonck, L. F. (1997) · Blood · doi:10.1182/blood.v90.10.4206 · Cited by 291
Dores, G. M., Landgren, O., McGlynn, K. A., Curtis, R. E., Linet, M. S., & Devesa, S. S. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07421.x · Cited by 291
Palumbo, A., Bringhen, S., Kumar, S. K., Lupparelli, G., Usmani, S., Waage, A., Larocca, A., van der Holt, B., Musto, P., Offidani, M., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70609-0 · Cited by 289
Self-citationLokhorst, H. M., Schattenberg, A., Cornelissen, J. J., van Oers, M. H. J., Fibbe, W., Russell, I., Donk, N. W. C. J. V. D., & Verdonck, L. F. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.16.3031 · Cited by 286
Roussel, M., Lauwers-Cances, V., Robillard, N., Hulin, C., Leleu, X., Benboubker, L., Marit, G., Moreau, P., Pegourie, B., Caillot, D., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.8164 · Cited by 266
Analysis of Herpes Zoster Events Among Bortezomib-Treated Patients in the Phase III APEX Study
Chanan-Khan, A., Sonneveld, P., Schuster, M. W., Stadtmauer, E. A., Facon, T., Harousseau, J.-L., Ben-Yehuda, D., Lonial, S., Goldschmidt, H., Reece, D., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.9641 · Cited by 263
Kumar, S. K., Berdeja, J. G., Niesvizky, R., Lonial, S., Laubach, J. P., Hamadani, M., Stewart, A. K., Hari, P., Roy, V., Vescio, R., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71125-8 · Cited by 262
Self-citationStadtmauer, E. A., Pasquini, M. C., Blackwell, B., Hari, P., Bashey, A., Devine, S., Efebera, Y., Ganguly, S., Gasparetto, C., Geller, N., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.00685 · Cited by 259
Self-citationMateos, M.-V., Nahi, H., Legiec, W., Grosicki, S., Vorobyev, V., Spicka, I., Hungria, V., Korenkova, S., Bahlis, N., Flogegard, M., et al. (2020) · The Lancet Haematology · doi:10.1016/s2352-3026(20)30070-3 · Cited by 254
Durie, B. G. M., Hoering, A., Sexton, R., Abidi, M. H., Epstein, J., Rajkumar, S. V., Dispenzieri, A., Kahanic, S. P., Thakuri, M. C., Reu, F. J., et al. (2020) · Blood Cancer Journal · doi:10.1038/s41408-020-0311-8 · Cited by 253
Kumar, S. K., Jacobus, S. J., Cohen, A. D., Weiss, M., Callander, N., Singh, A. K., Parker, T. L., Menter, A., Yang, X., Parsons, B., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30452-6 · Cited by 245
Self-citationDimopoulos, M. A., Gay, F., Schjesvold, F., Beksac, M., Hajek, R., Weisel, K. C., Goldschmidt, H., Maisnar, V., Moreau, P., Min, C. K., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(18)33003-4 · Cited by 237
Baz, R., Li, L., Kottke-Marchant, K., Srkalovic, G., McGowan, B., Yiannaki, E., Karam, M. A., Faiman, B., Jawde, R. A., Andresen, S., et al. (2005) · Mayo Clinic Proceedings · doi:10.4065/80.12.1568 · Cited by 228
Dispenzieri, A., Rajkumar, S. V., Gertz, M. A., Lacy, M. Q., Kyle, R. A., Greipp, P. R., Witzig, T. E., Lust, J. A., Russell, S. J., Hayman, S. R., et al. (2007) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)61029-x · Cited by 223
Self-citationOsterborg, A., Boogaerts, M., Cimino, R., Essers, U., Holowiecki, J., Juliusson, G., Jager, G., Najman, A., & Peest, D. (1996) · Blood · doi:10.1182/blood.v87.7.2675.bloodjournal8772675 · Cited by 202
Kneppers, E., van der Holt, B., Kersten, M.-J., Zweegman, S., Meijer, E., Huls, G., Cornelissen, J. J., Janssen, J. J., Huisman, C., Cornelisse, P. B., et al. (2011) · Blood · doi:10.1182/blood-2011-04-348292 · Cited by 193
Mateos, M.-V., Hernández, M.-T., Giraldo, P., de la Rubia, J., de Arriba, F., Corral, L. L., Rosiñol, L., Paiva, B., Palomera, L., Bargay, J., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30124-3 · Cited by 193
Reeder, C. B., Reece, D. E., Kukreti, V., Chen, C., Trudel, S., Laumann, K., Hentz, J., Pirooz, N. A., Piza, J. G., Tiedemann, R., et al. (2010) · Blood · doi:10.1182/blood-2010-02-271676 · Cited by 190
Gutiérrez, N. C., Castellanos, M. V., Martín, M. L., Mateos, M. V., Hernández, J. M., Fernández, M., Carrera, D., Rosiñol, L., Ribera, J. M., Ojanguren, J. M., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404413 · Cited by 185
Lokhorst, H. M., Wu, K., Verdonck, L. F., Laterveer, L. L., van de Donk, N. W. C. J., van Oers, M. H. J., Cornelissen, J. J., & Schattenberg, A. V. (2004) · Blood · doi:10.1182/blood-2003-11-3862 · Cited by 178
Donor leukocyte infusions for multiple myeloma
Salama, M., Nevill, T., Marcellus, D., Parker, P., Johnson, M., Kirk, A., Porter, D., Giralt, S., Levine, J., Drobyski, W., et al. (2000) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1702685 · Cited by 177
Initial results in the assessment of multiple myeloma using 18F-FDG PET
Schirrmeister, H., Bommer, M., Buck, A., Müller, S., Messer, P., Bunjes, D., Döhner, H., Bergmann, L., & Reske, S. (2002) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-001-0711-3 · Cited by 174
Holstein, S. A., Jung, S.-H., Richardson, P. G., Hofmeister, C. C., Hurd, D. D., Hassoun, H., Giralt, S., Stadtmauer, E. A., Weisdorf, D. J., Vij, R., et al. (2017) · The Lancet Haematology · doi:10.1016/s2352-3026(17)30140-0 · Cited by 173
Self-citationCook, G., Williams, C. D., Brown, J. M., Cairns, D. A., Cavenagh, J. D., Snowden, J. A., Ashcroft, A. J., Fletcher, M., Parrish, C., Yong, K., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70245-1 · Cited by 167
O'Donnell, E. K., Laubach, J. P., Yee, A. J., Chen, T., Huff, C. A., Basile, F. G., Wade, P. M., Paba‐Prada, C. E., Ghobrial, I. M., Schlossman, R. L., et al. (2018) · British Journal of Haematology · doi:10.1111/bjh.15261 · Cited by 166
Self-citationCommunity-Based Phase IIIB Trial of Three UPFRONT Bortezomib-Based Myeloma Regimens
Niesvizky, R., Flinn, I. W., Rifkin, R. M., Gabrail, N. Y., Charu, V., Clowney, B., Essell, J. H., Gaffar, Y., Warr, T. A., Neuwirth, R., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.7618 · Cited by 162
Second primary malignancies in multiple myeloma: an overview and IMWG consensus
Musto, P., Anderson, K. C., Attal, M., Richardson, P. G. G., Badros, A., Hou, J., Comenzo, R. L., Du, J., Durie, B. G. M., Miguel, J. F. S., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw606 · Cited by 159
Morgan, G. J., Davies, F. E., Gregory, W. M., Bell, S. E., Szubert, A. J., Cook, G., Drayson, M. T., Owen, R. G., Ross, F. M., Jackson, G. H., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3211 · Cited by 156
Bringhen, S., Petrucci, M. T., Larocca, A., Conticello, C., Rossi, D., Magarotto, V., Musto, P., Boccadifuoco, L., Offidani, M., Omedè, P., et al. (2014) · Blood · doi:10.1182/blood-2014-03-563759 · Cited by 154
Barlogie, B., Attal, M., Crowley, J. J., van Rhee, F., Szymonifka, J. D., Moreau, P., Durie, B. G. M., & Harousseau, J. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.6081 · Cited by 153
Cook, G., Ashcroft, A. J., Cairns, D. A., Williams, C. D., Brown, J. M., Cavenagh, J. D., Snowden, J. A., Parrish, C., Yong, K., Cavet, J., et al. (2016) · The Lancet Haematology · doi:10.1016/s2352-3026(16)30049-7 · Cited by 153
Multiple myeloma: 2011 update on diagnosis, risk-stratification, and management
Rajkumar, S. V. (2011) · American Journal of Hematology · doi:10.1002/ajh.21913 · Cited by 152
Mellqvist, U., Gimsing, P., Hjertner, Ø., Lenhoff, S., Laane, E., Remes, K., Steingrímsdóttir, H., Abildgaard, N., Ahlberg, L., Blimark, C. H., et al. (2013) · Blood · doi:10.1182/blood-2012-11-464503 · Cited by 146
Zamagni, E., Nanni, C., Gay, F., Pezzi, A., Patriarca, F. F., Bellò, M., Rambaldi, I., Tacchetti, P., Hillengaß, J., Gamberi, B., et al. (2015) · Leukemia · doi:10.1038/leu.2015.291 · Cited by 144
Xiong, W., Wu, X., Starnes, S. E., Johnson, S., Haessler, J., Wang, S., Chen, L., Barlogie, B., Shaughnessy, J. D., & Zhan, F. (2008) · Blood · doi:10.1182/blood-2007-10-119123 · Cited by 143
Bisphosphonates in multiple myeloma: a network meta-analysis
Mhaskar, R., Redzepovic, J., Wheatley, K., Clark, O. A. C., Miladinovic, B., Glasmacher, A., Kumar, A., & Djulbegovic, B. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003188.pub3 · Cited by 130
Solitary plasmacytomas: Outcome and prognostic factors after definitive radiation therapy
Reed, V. K., Shah, J. J., Medeiros, L. J., Ha, C. S., Mazloom, A., Weber, D. M., Arzu, I., Orlowski, R. Z., Thomas, S. K., Shihadeh, F., et al. (2011) · Cancer · doi:10.1002/cncr.26031 · Cited by 130
Self-citationArnulf, B., Pylypenko, H., Grosicki, S., Karamanesht, I., Leleu, X., van de Velde, H., Feng, H., Cakana, A., Deraedt, W., & Moreau, P. (2012) · Haematologica · doi:10.3324/haematol.2012.067793 · Cited by 127
Merz, M., Hielscher, T., Wagner, B., Sauer, S., Shah, S., Raab, M., Jauch, A. T., Neben, K., Hose, D., Egerer, G., et al. (2014) · Leukemia · doi:10.1038/leu.2014.75 · Cited by 122
Radiotherapy in the management of plasma cell tumors.
Hu, K. S., & Yahalom, J. (2000) · PubMed · Cited by 119
Jimenez-Zepeda, V. H., Mikhael, J. R., Winter, A., Franke, N., Masih‐Khan, E., Trudel, S., Chen, C. I., Kukreti, V., & Reece, D. E. (2011) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2011.10.044 · Cited by 117
Management of multiple myeloma: a systematic review and critical appraisal of published studies
Kumar, A., Loughran, T., Alsina, M., Durie, B. G., & Djulbegovic, B. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01077-5 · Cited by 113
Paiva, B., Vídriales, M., Pérez, J. J., Mateo, G., Montalbán, M.-Á., Mateos, M., Bladé, J., Lahuerta, J. J., Orfao, A., & Miguel, J. F. S. (2009) · Haematologica · doi:10.3324/haematol.2009.009100 · Cited by 110
Siontis, B. L., Kumar, S. K., Dispenzieri, A. A., Drake, M. T., Lacy, M. Q., Buadi, F. K., Dingli, D., Kapoor, P., Gonsalves, W. I., Gertz, M. A., et al. (2015) · Blood Cancer Journal · doi:10.1038/bcj.2015.87 · Cited by 102
Self-citationAlsina, M., Becker, P. S., Zhong, X., Adams, A. J., Hari, P., Rowley, S. D., Stadtmauer, E. A., Vesole, D. H., Logan, B. R., Weisdorf, D. J., et al. (2014) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2014.04.014 · Cited by 101
Ross, F. M., Chiecchio, L., Dagrada, G. P., Protheroe, R. K. M., Stockley, D. M., Harrison, C. J., Cross, N. C. P., Szubert, A. J., Drayson, M. T., Morgan, G. J., et al. (2010) · Haematologica · doi:10.3324/haematol.2009.016329 · Cited by 101
Impact of early relapse after auto-SCT for multiple myeloma
Kumar, S. K., Mahmood, S., Lacy, M. Q., Dispenzieri, A. A., Hayman, S. R., Buadi, F. K., Dingli, D., Rajkumar, S. V., Litzow, M. R., & Gertz, M. A. (2008) · Bone Marrow Transplantation · doi:10.1038/bmt.2008.180 · Cited by 99
Self-citationvan de Donk, N. W. C. J., Kröger, N. M., Hegenbart, U., Corradini, P., Miguel, J. F. S., Goldschmidt, H., Pérez‐Simón, J. A., Zijlmans, M., Raymakers, R. A. P., Montefusco, V., et al. (2006) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705393 · Cited by 99
Second auto-SCT is safe and effective salvage therapy for relapsed multiple myeloma
Olin, R. L., Vogl, D. T., Porter, D., Luger, S. M., Schuster, S. J., Tsai, D. E., Siegel, D. L., Cook, R. J., Mangan, P. A., Cunningham, K., et al. (2008) · Bone Marrow Transplantation · doi:10.1038/bmt.2008.334 · Cited by 99
Hahn, T., Wingard, J. R., Anderson, K. C., Bensinger, W., Berenson, J. R., Brozeit, G., Carver, J. R., Kyle, R. A., & McCarthy, P. L. (2003) · Transplantation and Cellular Therapy · doi:10.1053/bbmt.2003.50002 · Cited by 93
Kumar, S. K., Dispenzieri, A. A., Fraser, R. A., Fei, M., Akpek, G., Cornell, R. F., Kharfan‐Dabaja, M. A., Freytes, C. O., Hashmi, S. K., Hildebrandt, G. C., et al. (2017) · Leukemia · doi:10.1038/leu.2017.331 · Cited by 93
Self-citationPecherstorfer, M., Steinhauer, E. U., Rizzoli, R., Wetterwald, M., & Bergstr�m, B. (2003) · Supportive Care in Cancer · doi:10.1007/s00520-003-0477-1 · Cited by 83
Hulin, C., Belch, A. R., Shustik, C., Petrucci, M. T., Dührsen, U., Lu, J., Song, K., Rodon, P., Pegourié, B., Garderet, L., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.66.7295 · Cited by 83
Zonder, J. A., Crowley, J. J., Hussein, M. A., Bolejack, V., Moore, D. F., Whittenberger, B. F., Abidi, M. H., Durie, B. G. M., & Barlogie, B. (2007) · Blood · doi:10.1182/blood.v110.11.77.77 · Cited by 83
18F-FDG PET/CT in myeloma with presumed solitary plasmocytoma of bone.
Nanni, C., Rubello, D., Zamagni, E., et al. (2008) · PubMed · Cited by 80
Durable remission with salvage second autotransplants in patients with multiple myeloma
Shah, N., Ahmed, F., Bashir, Q., Qureshi, S., Dinh, Y. T., Rondón, G., Wen, S., Thall, P. F., Khan, H., Giralt, S., et al. (2011) · Cancer · doi:10.1002/cncr.26662 · Cited by 78
Major, P. P., & Coleman, R. E. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90261-1 · Cited by 77
Usmani, S. Z., Sexton, R. E., Hoering, A., Heuck, C. J., Nair, B. P., Waheed, S., Alsayed, Y. M., Chauhan, N., Ahmad, N., Atrash, S., et al. (2012) · Blood · doi:10.1182/blood-2012-04-421883 · Cited by 75
The role of second autografts in the management of myeloma at first relapse.
Alvares, C. L., Davies, F. E., Horton, C., Patel, G. W., Powles, R., & Morgan, G. J. (2006) · PubMed · Cited by 74
Kühnemund, A., Liebisch, P., Bauchmüller, K., Hausen, A. Z., Veelken, H., Wäsch, R., & Engelhardt, M. M. (2008) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-008-0470-7 · Cited by 72
Management of treatment-related adverse events in patients with multiple myeloma
Mateos, M. (2010) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(10)70009-8 · Cited by 70
Stadtmauer, E. A., Pasquini, M. C., Blackwell, B., Knust, K., Bashey, A., Devine, S. M., Efebera, Y. A., Ganguly, S., Gasparetto, C., Geller, N. L., et al. (2016) · Blood · doi:10.1182/blood.v128.22.lba-1.lba-1 · Cited by 70
Self-citationYimer, H. A., Melear, J. M., Faber, E. A., Bensinger, W., Burke, J. M., Narang, M., Stevens, D. A., Gunawardena, S. W., Lutska, Y., Qi, K., et al. (2019) · British Journal of Haematology · doi:10.1111/bjh.15806 · Cited by 69
Mai, E. K., Benner, A., Bertsch, U., Brossart, P., Hänel, A., Kunzmann, V., Naumann, R., Neben, K., Egerer, G., Ho, A. D., et al. (2016) · British Journal of Haematology · doi:10.1111/bjh.13994 · Cited by 67
Kumar, S. K., Lacy, M. Q., Hayman, S. R., Stewart, K., Buadi, F. K., Allred, J. B., Laumann, K. M., Greipp, P. R., Lust, J. A., Gertz, M. A., et al. (2011) · American Journal of Hematology · doi:10.1002/ajh.22053 · Cited by 64
Self-citationCook, G., Liakopoulou, E., Pearce, R., Cavet, J., Morgan, G. J., Kirkland, K., Lee, J., Davies, F. E., Hall, R., Rahemtulla, A., et al. (2011) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2011.04.005 · Cited by 63
Autologous retransplantation for patients with recurrent multiple myeloma
Sellner, L., Heiß, C., Benner, A., Raab, M. S., Hillengaß, J., Hose, D., Lehners, N., Egerer, G., Ho, A. D., Goldschmidt, H., et al. (2013) · Cancer · doi:10.1002/cncr.28104 · Cited by 59
Donor lymphocyte infusions for multiple myeloma: clinical results and novel perspectives
Zeiser, R., Bertz, H., Spyridonidis, A., Houet, L., & Finke, J. (2004) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1704670 · Cited by 56
Fenk, R. R., Liese, V., Neubauer, F., Bruns, I., Kondakci, M., Balleisen, S., Saure, C., Schröder, T., Haas, R. R., & Kobbe, G. (2011) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2011.575967 · Cited by 54
Ayuk, F. A., Shimoni, A., Nagler, A., Schwerdtfeger, R., Kiehl, M. G., Sayer, H. G., Zabelina, T., Zander, A. R., & Kröger, N. M. (2003) · Leukemia · doi:10.1038/sj.leu.2403252 · Cited by 53
Bygrave, C., Pawlyn, C., Davies, F. E., Craig, Z., Cairns, D. A., Hockaday, A., Jenner, M. W., Cook, G., Drayson, M. T., Owen, R. G., et al. (2020) · British Journal of Haematology · doi:10.1111/bjh.16793 · Cited by 51
Cavo, M., Petrucci, M. T., Raimondo, F. D., Zamagni, E., Gamberi, B., Crippa, C., Marzocchi, G., Grasso, M., Ballanti, S., Vincelli, D. I., et al. (2016) · Blood · doi:10.1182/blood.v128.22.991.991 · Cited by 50
Putkonen, M., Kairisto, V., Juvonen, V., Pelliniemi, T., Rauhala, A., Itälä‐Remes, M., & Remes, K. (2010) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2010.01510.x · Cited by 49
Burzynski, J. A., Toro, J. J., Patel, R. C., Lee, S., Greene, R. E., Ochoa-Bayona, J. L., Frei, C. R., & Freytes, C. O. (2009) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190903085936 · Cited by 46
Comparative genomic hybridisation identifies two variants of smoldering multiple myeloma
Rosiñol, L., Carrió, A., Bladé, J., Queralt, R., Aymerich, M., Cibeira, M., Esteve, J., Rozman, M., Campo, E., & Montserrat, E. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05673.x · Cited by 46
Kaufman, J. L., Nooka, A. K., Vrana, M., Gleason, C. L., Heffner, L. T., & Lonial, S. (2010) · Cancer · doi:10.1002/cncr.25143 · Cited by 45
Dytfeld, D., Jasielec, J. K., Griffith, K. A., Lebovic, D., Vesole, D. H., Jagannath, S., Al-Zoubi, A., Anderson, T., Detweiler‐Short, K., Stockerl-Goldstein, K. E., et al. (2014) · Haematologica · doi:10.3324/haematol.2014.110395 · Cited by 45
Self-citationAuner, H. W., Szydlo, R., Rone, A., Chaidos, A., Giles, C. M., Kanfer, E., Macdonald, D. H. C., Marín, D., Milojković, D., Pavlů, J., et al. (2013) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2013.773998 · Cited by 44
Kastritis, E., Ρούσσου, Μ., Eleutherakis‐Papaiakovou, E., Gavriatopoulou, M., Migkou, M., Gika, D., Fotiou, D., Kanellias, N., Ziogas, D. C., Ntanasis‐Stathopoulos, I., et al. (2020) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2019.10.014 · Cited by 44
Reeder, C. B., Reece, D. E., Kukreti, V., Mikhael, J. R., Chen, C. I., Trudel, S., Laumann, K. M., Vohra, H. S., Fonseca, R., Bergsagel, P. L., et al. (2014) · British Journal of Haematology · doi:10.1111/bjh.13004 · Cited by 42
Dimopoulos, M. A., Cheung, M. C., Roussel, M., Liu, T., Gamberi, B., Kolb, B., Derigs, H. G., Eom, H., Merzoug, K. B., Lenain, P., et al. (2015) · Haematologica · doi:10.3324/haematol.2015.133629 · Cited by 40
Korde, N., Zingone, A., Kwok, M., Manasanch, E. E., Bhutani, M., Tageja, N., Kazandjian, D. G., Mailankody, S., Costello, R., Zhang, Y., et al. (2013) · Blood · doi:10.1182/blood.v122.21.538.538 · Cited by 39
Efficacy of prophylactic warfarin for prevention of thalidomide-related deep venous thrombosis
Ikhlaque, N., Seshadri, V., Kathula, S. K., & Baumann, M. A. (2006) · American Journal of Hematology · doi:10.1002/ajh.20625 · Cited by 39
Niesvizky, R., Flinn, I. W., Rifkin, R. M., Gabrail, N. Y., Charu, V., Clowney, B., Essell, J. H., Gaffar, Y., Warr, T. A., Neuwirth, R. B., et al. (2011) · Blood · doi:10.1182/blood.v118.21.478.478 · Cited by 38
Dimopoulos, M. A., Grosicki, S., Wiktor-Jędrzejczak, W., Nahi, H., Gruber, A., Hansson, M., Gupta, N., Byrne, C., Labotka, R., Teng, Z., et al. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.09.011 · Cited by 33
Self-citationBringhen, S., D’Agostino, M., Paoli, L. D., Montefusco, V., Liberati, A. M., Galieni, P., Grammatico, S., Muccio, V. E., Esma, F., Angelis, C. D., et al. (2017) · Leukemia · doi:10.1038/leu.2017.327 · Cited by 32
Hinge, M., Andersen, K., Lund, T., Jørgensen, H. B., Holdgaard, P. C., Ormstrup, T. E., Ostergaard, L. L., & Plesner, T. (2016) · Haematologica · doi:10.3324/haematol.2016.146092 · Cited by 31
Miguel, J. F. S., Mateos, M., González, V., Dimopoulos, M. A., Kastritis, E., Hájek, R., Rodríguez, C. F. D. L., Morgan, G. J., Merlini, G., Mangiacavalli, S., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.2019.37.15_suppl.8000 · Cited by 29
Self-citationHigh-dose therapy in multiple myeloma and primary amyloidosis: an overview.
Kyle, R. A. (1999) · PubMed · Cited by 26
Bringhen, S., Mina, R., Petrucci, M. T., Gaidano, G., Ballanti, S., Musto, P., Offidani, M., Spada, S., Benevolo, G., Ponticelli, E., et al. (2019) · Haematologica · doi:10.3324/haematol.2018.208272 · Cited by 25
Kumar, S. K., Buadi, F. K., LaPlant, B. R., Halvorson, A. E., Leung, N., Kapoor, P., Dingli, D., Gertz, M. A., Go, R. S., Bergsagel, P. L., et al. (2018) · Blood Cancer Journal · doi:10.1038/s41408-018-0106-3 · Cited by 23
Self-citationKorde, N., Zingone, A., Kwok, M., Manasanch, E. E., Costello, R., Zuchlinski, D., Mulquin, M., Marić, I., Calvo, K. R., Braylan, R. C., et al. (2012) · Blood · doi:10.1182/blood.v120.21.732.732 · Cited by 21
Moreau, P., Hulin, C., Macro, M., Caillot, D., Chaleteix, C., Roussel, M., Garderet, L., Royer, B., Bréchignac, S., Tiab, M., et al. (2015) · Blood · doi:10.1182/blood.v126.23.393.393 · Cited by 20
Boccia, R. V., Bessudo, A., Agajanian, R., Conkling, P., Harb, W. A., Yang, H., Pinchasik, D. E., Kimball, A. S., & Berenson, J. R. (2017) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2017.05.009 · Cited by 19
Okazuka, K., Ishida, T., Nashimoto, J., Uto, Y., Sato, K., Miyazaki, K., Ogura, M., Yoshiki, Y., Abe, Y., Tsukada, N., et al. (2019) · European Journal Of Haematology · doi:10.1111/ejh.13349 · Cited by 19
Sonneveld, P., van der Holt, B., Segeren, C. M., Vellenga, E., Raymakers, R. A. P., Verhoef, G. E. G., Schaafsma, R., van Oers, M. H. J., Weijermans, P., Fibbe, W. E., et al. (2004) · Blood · doi:10.1182/blood.v104.11.948.948 · Cited by 16
Lenalidomide Maintenance Therapy In Multiple Myeloma: A Meta-Analysis Of Randomized Trials
Singh, P. P., Kumar, S. K., LaPlant, B. R., Gertz, M. A., Dispenzieri, A. A., Bergsagel, P. L., Lacy, M. Q., Singh, S., Roy, V., Buadi, F. K., et al. (2013) · Blood · doi:10.1182/blood.v122.21.407.407 · Cited by 15
Self-citationZepeda, V. H. J., Duggan, P. R., Neri, P. E., & Bahlis, N. J. (2014) · Blood · doi:10.1182/blood.v124.21.5751.5751 · Cited by 15
Utilization Patterns of Single Fraction Radiation Therapy for Multiple Myeloma
Salgado, L. R., Chang, S., Ru, M., Moshier, E. L., Ghiassi–Nejad, Z., Lazarev, S., Smith, W., Thompson, M., & Dharmarajan, K. V. (2019) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2019.02.010 · Cited by 7
Cited by
Teclistamab in Relapsed or Refractory Multiple Myeloma
Moreau, P., Garfall, A. L., van de Donk, N. W. C. J., Nahi, H., San-Miguel, J. F., Oriol, A., Nooka, A. K., Martin, T., Rosinol, L., Chari, A., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2203478 · Cited by 1,269
Self-citationMartin, T., Usmani, S. Z., Berdeja, J. G., Agha, M., Cohen, A. D., Hari, P., Avigan, D., Deol, A., Htut, M., Lesokhin, A., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.22.00842 · Cited by 663
Self-citationD'Agostino, M., Cairns, D. A., Lahuerta, J. J., Wester, R., Bertsch, U., Waage, A., Zamagni, E., Mateos, M.-V., Dall'Olio, D., van de Donk, N. W. C. J., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.02614 · Cited by 429
Exploring immunotherapy in colorectal cancer
Weng, J., Li, S., Zhu, Z., Liu, Q., Zhang, R., Yang, Y., & Li, X. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01294-4 · Cited by 355
Yoshino, T., Di Bartolomeo, M., Raghav, K., Masuishi, T., Loupakis, F., Kawakami, H., Yamaguchi, K., Nishina, T., Wainberg, Z., Elez, E., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38032-4 · Cited by 178
Metadata
- Authors
- Kumar, S. K., Callander, N. S., Adekola, K., Anderson, L., Baljevic, M., Campagnaro, E., Castillo, J. J., Chandler, J. C., Costello, C., Efebera, Y., Faiman, M., Garfall, A., Godby, K., Hillengass, J., Holmberg, L., Htut, M., Huff, C. A., Kang, Y., Hultcrantz, M., Larson, S., Liedtke, M., Martin, T., Omel, J., Shain, K., Sborov, D., Stockerl-Goldstein, K., Weber, D., Keller, J., & Kumar, R.
- Venue
- Journal of the National Comprehensive Cancer Network
- Publisher
- Harborside Press, LLC
- Published
- 2020-12
- Volume
- 18
- Issue
- 12
- Pages
- 1685-1717
- ISSN
- 1540-1405 (ISSN-L)
- 1540-1413
- OpenAlex
- W3112088296
- Cited by
- 277
- References
- 173
- FWCI
- 27.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.